Market revenue in 2023 | USD 497.4 million |
Market revenue in 2030 | USD 710.0 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Roche Holding AG ADR, Qiagen NV, Siemens Healthineers AG ADR, Becton Dickinson & Co, Illumina Inc, Epigenomics AG, Koninklijke Philips NV, FUJIFILM Holdings Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to liver cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 58.5% in 2023. Horizon Databook has segmented the Germany liver cancer diagnostics market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
Rise in number of initiatives undertaken by the government to enhance screening of HCC is a major factor anticipated to drive growth in the near future. There is a considerable rise in deaths caused by HCC in patients suffering from liver cirrhosis. Thus, early diagnosis of the disease can help reduce health care costs.
A research study published in NCBI aims at summarizing the recommendations provided by German 3 Guideline for early detection of HCC. According to this guideline, the government recommends that individuals with liver cirrhosis should undergo regular screening to benefit from early diagnosis of tumor. Therefore, rise in such initiatives undertaken by the German government is expected to aid growth over forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany liver cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Germany liver cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account